Which factors predict cognitive decline in Parkinson's disease?

Por Caparros-Lefebvre, D, Pécheux, N, Petit, V, Duhamel, A, Petit, H
Publicado em 1995

Neuropsychological abnormalities in first degree relatives of patients with familial Parkinson's disease

Por Dujardin, K., Duhamel, A., Becquet, E., Grunberg, C., Defebvre, L., Destee, A.
Publicado em 1999

Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to (99m)Tc HmPAO SPECT data

Por Charpentier, P, Lavenu, I, Defebvre, L, Duhamel, A, Lecouffe, P, Pasquier, F, Steinling, M
Publicado em 2000

Adaptive changes of human islets to an obesogenic environment in the mouse

Por Gargani, S., Thévenet, J., Yuan, J. E., Lefebvre, B., Delalleau, N., Gmyr, V., Hubert, T., Duhamel, A., Pattou, F., Kerr-Conte, J.
Publicado em 2012

A blended cognitive behavioral intervention for patients with adjustment disorder with anxiety: A randomized controlled trial

Por Leterme, A.C., Behal, H., Demarty, A.L., Barasino, O., Rougegrez, L., Labreuche, J., Duhamel, A., Vaiva, G., Servant, D.
Publicado no Internet Interv (2020)

Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease

Por Halfvarson, J, Standaert-Vitse, A, Järnerot, G, Sendid, B, Jouault, T, Bodin, L, Duhamel, A, Colombel, J F, Tysk, C, Poulain, D
Publicado em 2005

Fréquence des acrosyndromes chez les patients avec infection sévère à SARS-CoV-2 en réanimation

Por Mille, B., Dezoteux, F., Fievet, C., Moreau, A.S., Poissy, J., Mathieu, D., Kipnis, E., Duhamel, A., Drumez, E., Buche, S., Staumont-Salle, D.
Publicado no Ann Dermatol Venereol (2020)

Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease

Por Devos, D, Krystkowiak, P, Clement, F, Dujardin, K, Cottencin, O, Waucquier, N, Ajebbar, K, Thielemans, B, Kroumova, M, Duhamel, A, Destée, A, Bordet, R, Defebvre, L
Publicado em 2007

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma The European Organisation for Research and Treatment of Cancer...

Por Penel, N, Glabbeke, M V, Mathoulin-Pelissier, S, Judson, I, Sleijfer, S, Bui, B, Schoffski, P, Ouali, M, Marreaud, S, Brouste, V, Duhamel, A, Hohenberger, P, Blay, J-Y
Publicado em 2011

High-affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis

Por Oxombre, B, Lee-Chang, C, Duhamel, A, Toussaint, M, Giroux, M, Donnier-Maréchal, M, Carato, P, Lefranc, D, Zéphir, H, Prin, L, Melnyk, P, Vermersch, P
Publicado no Br J Pharmacol (2015)

Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin

Por Ploquin, A, Olmos, D, Lacombe, D, A'Hern, R, Duhamel, A, Twelves, C, Marsoni, S, Morales-Barrera, R, Soria, J-C, Verweij, J, Voest, E E, Schöffski, P, Schellens, J H, Kramar, A, Kristeleit, R S, Arkenau, H-T, Kaye, S B, Penel, N
Publicado em 2012

MRI of the cervical spinal cord predicts respiratory dysfunction in ALS

Por Grolez, G., Kyheng, M., Lopes, R., Moreau, C., Timmerman, K., Auger, F., Kuchcinski, G., Duhamel, A., Jissendi-Tchofo, P., Besson, P., Laloux, C., Petrault, M., Devedjian, J. C., Pérez, Thierry, Pradat, Pierre François, Defebvre, L., Bordet, R., Danel-Brunaud, V., Devos, D.
Publicado no Sci Rep (2018)